| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $36.2M | — | -16.8% |
| Cost of Revenue | $16.4M | — | -20.1% |
| Gross Profit | $19.9M | — | -13.9% |
| R&D Expense | $1.4M | — | -19.3% |
| SG&A Expense | $18.2M | — | -17.4% |
| Operating Income | -$901K | — | +74.3% |
| Pre-tax Income | -$1.0M | — | +71.7% |
| Income Tax | $8K | — | -11.1% |
| Net Income | -$1.0M | — | +71.6% |
| EPS (Basic) | -$0.03 | — | +70.0% |
| EPS (Diluted) | -$0.03 | — | +70.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.2M | -15.7% | -25.5% |
| Accounts Receivable | $514K | -83.5% | — |
| Inventory | $21.5M | +16.6% | -2.5% |
| Current Assets | $33.5M | -3.3% | -12.1% |
| Total Assets | $51.1M | -3.8% | -14.7% |
| Current Liabilities | $26.2M | -5.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$683K | — | +90.1% |
| Capital Expenditures | $294K | — | -45.7% |
| Investing Cash Flow | -$294K | — | +91.3% |
| Financing Cash Flow | -$388K | — | +27.6% |
| Free Cash Flow | -$977K | — | +86.8% |
| +1.5% |
| Long-term Debt | $7.5M | +11.9% | +0.0% |
| Total Liabilities | $43.7M | -3.6% | -6.5% |
| Stockholders' Equity | -$17.4M | -2.3% | -49.4% |